Investors

Media Coverage

NASDAQ: ENVB

Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts

Media Coverage

The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of [Vice]

January 24, 2022

Enveric Names New Chief Medical Officer [Green Market Report]

December 15, 2021

This Isn’t the 60s Again’: Psychedelics Business Takes Off Amid Culture Clash [The Guardian]

December 12, 2021

What Did You Miss at This Year’s Wonderland Psychedelic Conference? [Cannabis & Tech Today]

December 3, 2021

Enveric Biosciences’ CBD-Based Product Reduces Dermatitis Severity In Animal Study [Benzinga]

November 18, 2021

CBD News Roundup: Study Shows Effectiveness of CBDistillery Sleep Product [CBD Insider]

November 16, 2021

Enveric Biosciences Sees Opportunity In Both Cannabinoids, Psychedelics [Green Market Report]

November 16, 2021

Highlights on Enveric Biosciences [Psychedelic Spotlight]

October 25, 2021

Enveric Enters Next Phase Of CBD Cancer Treatment Trial [Candid Chronicle]

July 12, 2021

Enveric Biosciences and MagicMed [The Green Rush Podcast]

July 8, 2021

‹
1
…
6
7
8
9
10
…
12
›

Company

Team

Psybrary™

Pipeline

Investors

Contact

Sign Up for Updates

© 2025 Enveric Biosciences | Terms of Use | Privacy Policy

Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.